Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 12, 2016Virtual Press Office and PR Newswire: General Trade show news
Sanofi announced today the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the investigational titratable fixed-ratio combination of basal insulin...
-
Jun 12, 2016Virtual Press Office and PR Newswire: General Trade show news
New data from a completed Phase 3 trial show Trulicity® (dulaglutide) 1.5 mg significantly reduced hemoglobin A1c (A1C) and body weight as an add-on to insulin glargine without increasing the...
-
Jun 12, 2016Virtual Press Office and PR Newswire: General Trade show news
New analyses showed risk reductions were consistent across age groups for cardiovascular (CV) outcomes, including CV death, with Jardiance® (empagliflozin) compared with placebo when added to...
-
Jun 12, 2016Virtual Press Office and PR Newswire: General Trade show news
Industry leaders, developers and researchers at the American Diabetes Association's 76th Scientific Sessions are demonstrating how they are tapping into Watson cognitive computing to transform the...
-
Jun 11, 2016London Technology Week 2016: Macunx VR
Cambridge, UK: Kicking off London Tech Week 2016, Linguisticator and Macunx VR will host an unforgettable evening focused on the potential of VR, AR and mixed reality in education, life sciences...